Chargement en cours...
Optimizing antiviral agents for hepatitis B management in malignant lymphomas
The global scale of hepatitis B infection is well known but its impact is still being understood. Missed hepatitis B infection impacts lymphoma therapy especially increased risk of hepatitis B virus (HBV) reactivation and poor treatment outcomes. The presence of undiagnosed chronic hepatitis also un...
Enregistré dans:
| Publié dans: | Ann Transl Med |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
AME Publishing Company
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5326643/ https://ncbi.nlm.nih.gov/pubmed/28251118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.12.25 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|